Market revenue in 2023 | USD 13.4 million |
Market revenue in 2030 | USD 28.7 million |
Growth rate | 11.5% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.21% in 2023. Horizon Databook has segmented the Sweden deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden deep brain stimulation devices market is mainly driven by growing geriatric population, which has led to increase in the incidence of PD and other neurological disorders. Moreover, presence of well-developed healthcare system is another major factor driving the Sweden market.
The Swedish Neuroscience Institute is constantly trying to develop advanced deep brain stimulation devices to address Alzheimer’s disease.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account